Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.
The company today said it proposes offer for sale of $250 million of shares.
DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.
Source: Read Full Article
Lates News:
-
$ETH: MicroStrategy CEO Michael Saylor Questions the Soundness of Ethereum
-
BTC Bull Run Incoming? Bitcoin Supply on Exchanges Hits Six-Year Low
-
$BTC: Popular Crypto Analyst Points to Bullish Pattern Suggesting Bitcoin Could Trade at $80,000 Next Year
-
Bitcoin (BTC/USD) Price Analysis
-
Cryptos Rise Even As Markets Digest The FTX Developments